APT ALPHA PRO TECH LTD
Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 884269 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY7.8%
TTM net income YoY40.0%
TTM EPS YoY44.1%
Revenue 3-yr CAGR3.1%
Net income 3-yr CAGR11.7%
Margins
Gross margin38.6%
Operating margin8.7%
Net margin8.1%
FCF margin14.2%
EBITDA margin10.2%
Returns
ROE8.0%
ROA6.7%
ROIC (approx.)10.2%
Asset turnover0.83x
Leverage & solvency
Liabilities / assets17.2%
Debt / equity0.00x
Current ratio8.71x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.87x
Accruals ratio-5.9%
Payout ratio—
Capex / revenue1.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $16.60M | $18.67M | $14.59M | $13.86M | $14.79M | $16.67M | $13.82M | $13.82M |
| Cost of revenue | $9.67M | $11.70M | $9.07M | $8.72M | $8.92M | $10.54M | $8.43M | $8.63M |
| Gross profit | $6.94M | $6.98M | $5.52M | $5.15M | $5.87M | $6.13M | $5.39M | $5.19M |
| SG&A expense | $4.74M | $4.70M | $4.69M | $3.96M | $4.57M | $4.56M | $4.69M | $4.38M |
| Operating income | $1.97M | $2.01M | $580,000 | $952,000 | $1.10M | $1.33M | $455,000 | $674,000 |
| Income tax | $605,000 | $558,000 | $183,000 | $295,000 | $317,000 | $367,000 | $159,000 | $233,000 |
| Net income | $1.93M | $1.83M | $702,000 | $698,000 | $976,000 | $1.24M | $613,000 | $847,000 |
| EBITDA | $2.20M | $2.28M | $830,000 | $1.19M | $1.30M | $1.57M | $698,000 | $813,000 |
| EPS (basic) | 0.19 | 0.18 | 0.07 | — | 0.09 | 0.12 | 0.06 | — |
| EPS (diluted) | 0.19 | 0.18 | 0.07 | — | 0.09 | 0.12 | 0.06 | — |
| Weighted avg. shares (diluted) | 10.37M | 10.35M | 10.33M | — | 10.49M | 10.61M | 10.84M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $25.55M | $18.90M | $16.88M | $16.99M | $17.66M | $14.46M | $13.35M | $18.64M |
| Inventory | $17.85M | $18.65M | $22.05M | $23.60M | $23.48M | $22.36M | $23.57M | $22.73M |
| Current assets | $58.82M | $54.19M | $51.89M | $52.52M | $51.75M | $50.54M | $49.34M | $50.64M |
| PP&E, net | $7.83M | $7.97M | $8.10M | $8.23M | $8.21M | $8.31M | $8.41M | $8.52M |
| Goodwill | $55,000 | $55,000 | $55,000 | $55,000 | $55,000 | $55,000 | $55,000 | $55,000 |
| Total assets | $79.74M | $75.35M | $72.98M | $74.13M | $73.87M | $73.17M | $72.18M | $73.74M |
| Current liabilities | $6.75M | $3.18M | $2.62M | $4.06M | $3.67M | $3.02M | $2.31M | $3.12M |
| Total liabilities | $13.73M | $10.43M | $9.97M | $11.65M | $11.33M | $10.92M | $10.45M | $11.51M |
| Shareholders' equity | $66.01M | $64.92M | $63.01M | $62.48M | $62.54M | $62.25M | $61.73M | $62.23M |
| Shares outstanding | 10.18M | 10.12M | 10.13M | 10.13M | 10.28M | 10.41M | 10.60M | 10.82M |
| Cash flow statement | ||||||||
| Operating cash flow | $7.11M | $2.21M | $12,000 | $318,000 | $3.92M | $2.09M | -$3.96M | $2.41M |
| Capital expenditure | $83,000 | $142,000 | $117,000 | $267,000 | $99,000 | $138,000 | $135,000 | $1.44M |
| Free cash flow | $7.03M | $2.07M | -$105,000 | $51,000 | $3.82M | $1.95M | -$4.09M | $970,000 |
| Investing cash flow | -$83,000 | -$142,000 | -$117,000 | -$267,000 | -$99,000 | -$138,000 | -$135,000 | -$1.44M |
| Financing cash flow | -$384,000 | -$53,000 | $0 | -$721,000 | -$630,000 | -$838,000 | -$1.19M | -$728,000 |
| Depreciation & amortization | $226,000 | $268,000 | $250,000 | $239,000 | $203,000 | $240,000 | $243,000 | $139,000 |
| Stock-based compensation | $126,000 | $127,000 | $132,000 | $132,000 | $136,000 | $136,000 | $136,000 | $136,000 |
| Share buybacks | $384,000 | $99,000 | $0 | $713,000 | $624,000 | $830,000 | $1.18M | $721,000 |
Free plan shows the latest 8 periods; Pro shows all 68 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.